Particle swarm optimization framework for Parkinson's disease prediction | JoVE Visualize

Area of Science:

Biomedical Engineering
Computational Neuroscience
Artificial Intelligence in Medicine

Background:

Early diagnosis of Parkinson's disease (PD) is hindered by subtle initial symptoms, necessitating advanced detection methods.
Vocal biomarkers offer a non-invasive avenue for PD assessment, but their diagnostic potential requires sophisticated analytical frameworks.
Current diagnostic approaches may not fully capture the complexity of early PD indicators, leading to delayed intervention.

Purpose of the Study:

To develop and evaluate an advanced machine learning framework integrating particle swarm optimization (PSO) for enhanced Parkinson's disease detection using vocal biomarkers.
To unify acoustic feature selection and classifier hyperparameter tuning within a single computational architecture for improved predictive accuracy.
To assess the practical viability and clinical implications of PSO-optimized decision support systems for early neurodegenerative disease detection.

Main Methods:

A novel machine learning framework leveraging particle swarm optimization (PSO) was developed to optimize both feature selection and classifier hyperparameters for PD detection.
The PSO-enhanced models were systematically evaluated on two distinct clinical datasets (Dataset 1: 1,195 records, 24 features; Dataset 2: 2,105 records, 33 multidimensional features).
Performance metrics including accuracy, sensitivity, specificity, and Area Under the Curve (AUC) were compared against traditional machine learning classifiers.

Main Results:

For Dataset 1, the PSO model achieved 96.7% testing accuracy, outperforming the best traditional classifier (Bagging) by 2.6%, with 99.0% sensitivity and 94.6% specificity.
Dataset 2 demonstrated even greater improvements, with the PSO model reaching 98.9% accuracy (3.9% higher than LGBM) and a near-perfect AUC of 0.999.
The PSO optimization demonstrated practical viability with an average training time of 250.93 seconds for Dataset 2, indicating reasonable computational overhead.

Conclusions:

The proposed PSO-enhanced machine learning framework significantly improves the accuracy and discriminative capability for early Parkinson's disease detection using vocal biomarkers.
Intelligent optimization techniques like PSO hold substantial potential for developing practical clinical decision support systems for neurodegenerative diseases.
These findings suggest a promising direction for advancing early diagnosis and intervention strategies in Parkinson's disease management.